MediFind

Find a Doctor

Daniel Checketts

Gw Research Ltd
Male

Bio


Daniel Checketts is in Cambridge, United Kingdom. They have been an author on 9 peer reviewed articles in the past 15 years. Dr. Checketts's top three areas of expertise are Lennox-Gastaut Syndrome, Myoclonus Epilepsy Partial Seizure, and Myoclonic Epilepsy.

Contact

Cambridge, ENG, GB

Latest Research


Latest Advance
Study
  • Condition: Convulsive Seizure Frequency in Dravet Syndrome
  • Journal: JAMA neurology
  • Treatment Used: Adjunctive Oral Cannabidiol vs Placebo
  • Number of Patients: 199
  • Published —
This study evaluated the safety and effectiveness of a pharmaceutical formulation of cannabidiol, 10 and 20 mg/kg/d, versus placebo for adjunctive treatment of convulsive seizures in patients with Dravet syndrome.
Latest Advance
Study
  • Condition: Children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome
  • Journal: Epilepsy research
  • Treatment Used: Cannabidiol
  • Number of Patients: 607
  • Published —
The study researched long-term safety and effectiveness of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome.
Latest Advance
Study
  • Condition: Lennox-Gastaut syndrome
  • Journal: Epilepsia
  • Treatment Used: CBD
  • Number of Patients: 366
  • Published —
In this study, researchers evaluated the long-term outcomes of treating Lennox-Gastaut syndrome with CBD.

Clinical Trials


This doctor has not participated in any recent clinical trials.

Contact

Cambridge, ENG, GB

Insurance

Contact them to find out if they accept your insurance plan.